Skip to main content

Table 4 Antibodies, their clones, epitopes, pretreatments and dilutions used

From: Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease

 

Clone/type

Epitope (Immunogen)

Pre-treatment

Dilution

Source

Alpha-synuclein

42, Mouse IgG1

Rat aSN15-123

80% Formic acid for 1 hour

1:1000

Becton-Dickinson

Alpha-synuclein

Rabbit polyclonal

a.a. 111-131

80% Formic acid for 10 mins

1:2000

Millipore

Tau

AT8, mouse IgG1

Tau phosphorylated at Ser-202/Thr-205

None

1:800

Autogen bioclear

Tau

Rabbit Polyclonal

C terminal a.a. 243-441

None

1:800

Dako

Abeta

4G8, IgG2b

a.a. 17-24

80% FA for 1 hour

1:2000

Signet

Abeta

Rabbit polyclonal

Synthetic peptide corresponding to a.a. 1–16 of Abeta peptides 38, 40, and 42

80% FA for 1 hour

1:500

Synaptic systems

MRC1

Rabbit polyclonal

Macrophage mannose receptor 1 precursor recombinant protein epitope signature tag

Microwave in 10 mM citrate buffer pH 6 for 20 mins

1:1000

Prestige antibodies

Iba1

Rabbit polyclonal

Synthetic peptide corresponding to C-terminus of Iba1

Microwave in 10 mM citrate buffer pH 6 for 20 mins

1:400

Wako

CD68

PG-M1, IgG3

Fixative-resistant epitope on macrophage-restricted form of CD68

Microwave in 10 mM citrate buffer pH 6 for 20 mins

1:500

Dako

CD163

10D6, IgG1

Prokaryotic recombinant protein corresponding to domains 1–4 of N-terminal region of CD163

Microwave in 10 mM citrate buffer pH 6 for 20 mins

1:50

Novocastra

Fibrinogen

Rabbit polyclonal

Fibrinogen isolated from human plasma

Microwave in 10 mM citrate buffer pH 6 for 20 mins

1:5000

Dako